Lendlease: Chairman’s 932% Bet Versus CEO’s Exit Sales—Smart Money Waits for Inflection

The real signal from Lendlease's insider filings is a study in conflicting bets. On one side, you have a major whale wallet making a bold, concentrated bet. On the other, the outgoing CEO is quietly cashing out. Smart money will watch this tug-of-war closely.

The standout move is from Independent Chairman John Gillam. In November 2024, he spent AU$898k on stock at an average price of AU$6.88, boosting his holding by 932%. That was the biggest insider purchase in the last year. For a board leader, buying at a premium to the current price is a clear signal of skin in the game. It suggests deep, confident optimism about the company's trajectory, especially as the board points to FY27 as an inflection point.

Other non-executive directors have followed suit, albeit on a smaller scale. A non-executive director recently bought 6,000 shares via a distribution reinvestment plan, a small but notable signal of alignment. The broader insider pattern over the last year shows net buying, with purchases totaling AU$2.2m against sales of AU$450k. This collective action by the board and some executives provides a baseline of confidence.

Then there's the CEO's exit strategy. Outgoing Group CEO Tony Lombardo sold 277,688 shares in September 2025, a significant sale before his planned departure in August 2026. While such sales are common when executives leave, the timing and size create a lack of alignment. The man who led the strategic reset is selling a major chunk of his stake as he prepares to step down. This doesn't necessarily mean he's bearish, but it does mean his personal financial interest is decoupling from the stock's future performance.

The bottom line is that while the chairman's massive buy shows some smart money is bullish, the broader pattern of insider selling, particularly by the outgoing CEO, introduces a red flag. It creates a split signal: the board is betting big, but the leader of the turnaround is cashing out. For investors, this is a classic setup where the skin in the game is divided, and the smart money will be watching to see if the new leadership team can re-earn that confidence.

The Financial Reality: Operational Gains vs. Balance Sheet Writedowns

The numbers tell a split story. On one hand, the operational engine is firing. The core development and construction segment delivered EBITDA of $204 million, a strong showing that validates the strategic reset. The backlog is up, new work is being secured, and the company is executing its capital recycling program. This is the positive narrative management is pushing.

On the other side, the balance sheet is bleeding. The company reported a statutory loss after tax of $318 million for the half-year, a massive swing from a profit last year. That loss is driven by writedowns and provisions of $180 million, primarily in the capital release unit. In other words, the operational gains are being offset by a deliberate, non-cash write-down of assets and investments. This is the financial reality beneath the surface optimism.

The timing of leadership changes adds another layer of pressure. Both the CEO and CFO are leaving within the next six months. The outgoing CEO, Tony Lombardo, has already sold a significant portion of his stake in September 2025 before his planned departure. The board has framed this as a natural transition to a new phase, with FY27 as an inflection point. But for the smart money, the question is one of continuity. Who ensures the turnaround process keeps turning when the architects of the reset are stepping down? The operational gains are real, but they are being undermined by deeper financial pressures that require steady, hands-on management to resolve.

The bottom line is that Lendlease is in a classic turnaround limbo. The core business is improving, but the balance sheet is still being restructured, and the leadership team is changing. The smart money will watch to see if the incoming leadership can bridge this gap and turn the operational momentum into sustained, clean earnings. Until then, the writedowns and the leadership shuffle are the real signals.

Institutional Accumulation & What to Watch

The institutional tape is quiet, but the real test is the pace of asset divestment and provisioning discipline. For now, the smart money is waiting. The recent 7.5% drop in shares shows investors are focused on the slow pace of divestment and the massive writedowns and provisions of $180 million. Until these balance sheet clean-up efforts accelerate, institutional accumulation is likely to be cautious. The key catalyst is the full-year results in August 2026, which will confirm whether the company is truly on track for the FY27 inflection point the board has promised.

The near-term setup hinges on two critical, measurable actions. First, the speed and quality of asset sales. The strategic reset depends on converting portfolio holdings into cash to repair the balance sheet. A slow pace dilutes the value being rebuilt by operational gains. Second, provisioning discipline. The $180 million hit was a deliberate move to clear the books, but the company must now show it can manage future provisions without further surprises. These are the mechanics that will determine if insider buying is a smart bet or a trap.

The biggest risk to the positive signal is continued insider selling. While the chairman's AU$898k purchase is a bullish bet, the broader pattern of sales, particularly by departing executives, creates uncertainty. The outgoing CEO has already sold a major stake in September 2025, and the CFO is also leaving. If other insiders follow suit, it could dilute the confidence shown by the board. The smart money will watch for any further sales as a potential red flag.

The bottom line is that value is being rebuilt through operational execution, but it's being diluted by balance sheet pressures and leadership change. The institutional accumulation we're seeing is likely a wait-and-see bet. The real signal will come from the August results, which must show tangible progress on divestments and a clean provisioning path. Until then, the stock's fate rests on the company's ability to choreograph a flawless balance sheet recovery.